BRIEF-Biorestorative Therapies' BRTX-100 Shows Sustained Pain & Functional Improvements In Chronic Lumbar Disc Disease

BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc.

BRTX

0.00

May 7 (Reuters) - BioRestorative Therapies Inc BRTX.O:

  • BIORESTORATIVE THERAPIES REPORTS EXPANDED PHASE 2 BLINDED DATASET FOR BRTX-100 SHOWING SUSTAINED PAIN AND FUNCTIONAL IMPROVEMENTS IN CHRONIC LUMBAR DISC DISEASE

  • BIORESTORATIVE THERAPIES INC - 52% OF PATIENTS ACHIEVE ≥50% IMPROVEMENT IN VAS PAIN AND ODI FUNCTION AT 52 WEEKS

  • BIORESTORATIVE THERAPIES INC - 52-WEEK COHORT INCREASES TO 25 PATIENTS WITH NO DOSE-LIMITING TOXICITY SAFETY SIGNALS

Source text: ID:nGNX4nVmrS

Further company coverage: BRTX.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.